期刊文献+

重组质粒二级结构对丙型肝炎病毒E2蛋白基因表达的影响 被引量:1

Effect of gene structure of recombine plasmid in HCV/E2 protein Expression
下载PDF
导出
摘要 将含HCV/E2基因的重组质粒 pUC18/HCV -E2的BamHI酶切基因片段和NcoⅠ +HindⅢ酶切基因片段分别克隆到原核表达载体pRSETHis中 ,构建两株重组HCV/E2重组表达质粒 pRSET·C/E2和 pRSET·A/E2。在诱导表达中 pRSET·A/E2的外源基因获得了高效表达 ,而 pRSET·C/E2的外源基因完全未得到表达。 HCV/E2 gene fragment was obtained from plasmid pUC18/HCV E2 by digesting with endonuclease BamHI,another E2 fragment was obtained from same pladmid by digesting with NcoⅠ and HindⅢ.Two fragments were inserted into proper reading frame of expression vector pRSETHis respectively,and recombiant expression plasmids of pRSET·C/E2 and pRSET·A/E2were constructed.these recombinant plasmids were transformed into E.coli.TOP10 strain and induced by IPTG.The expressive conditions were optimized,the induced purpose protein was detected and analysed by SDS PAGE and Western blot.The pRSET·A/E2 have a high level expression and the E2 fusion protein accounted for 20% in the total proteins of host bacteria meanwhile the pRSET·C/E2 have not detected expressive purpose protein entirely.We guess the reason of that is due to a very stable RNA secondary strcucture within mRNA translation initial region in pRSET·C/E2.
出处 《微生物学免疫学进展》 2003年第4期19-23,共5页 Progress In Microbiology and Immunology
关键词 丙型肝炎病毒 重组质粒 基因表达 E2蛋白 HCV Recombinant plasmid Gene expression
  • 相关文献

参考文献10

  • 1单梅梅,刘克洲,祝文娴.病毒逃避免疫监视机制的研究进展[J].国外医学(流行病学.传染病学分册),1998,25(4):148-152. 被引量:7
  • 2曾蔚蓝,阮力.中国人丙型肝炎病毒膜蛋白和非结构区1(E1,E2/NS1)的基因克隆和序列分析[J].病毒学报,1992,8(4):360-363. 被引量:3
  • 3李兵.丙型肝炎病毒分子生物学与基因疫苗[J].国外医学(病毒学分册),1999,6(4):102-105. 被引量:1
  • 4Choo QL,Kuo G,Weiner AJ,et al. Isolation of a cDNA clone derived from a blood-borne non-A,non*B viral hepatitis genome[J].Science 1989,244 : 1-3.
  • 5Kato N,Hijikato M,Octsyama Y,et al. Molecular cloning of the human hepatitis C virus genome fnxn Japanese patients with non - A,nonB hepatitis[J] . Proc Natl Acad Sci USA 1990,87:9524-9528.
  • 6Piled P, Uematsu Y, Campagnoli S,et el. Binding of hepatitis C virus to CD81 [J]. Science 1998, 282:938-941.
  • 7Weiner A J , Geysen H M, Christphorson C, et al. Evidence for immune selection of hepatitis C virus ( HCV ) putative envelope glycoprotein variants:Potential role in chronic HCV infections[J].Proc Natl Acad Sci USA 1992,89:3468-3472.
  • 8Shimizu Y K, Hijikata M, lwamoto A,et al. Neutralizing antibodies against hepatitis C virus and the emelgence of neutralization escape mutant viruaeap[J]. J Viral 1994,68: 1494-1500.
  • 9Rosa D, Campagnoli S, Moretto C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glyeuprotein 2 binding to target cells[J]. Proc Natl Acad Sci USA 1995.93:1759-1763.
  • 10Farci P, Alberet H J, Wong D C, et 81. Prevention of hepatitis C virus infection in chimpanizees after antibody-mediated in vitro neutmlization[J]. Proc Natl Acad Sci USA 1994,9 1:7792-7796.

二级参考文献3

共引文献8

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部